Efficacy and Tolerability of Erenumab and Topiramate for Prevention of Chronic Migraine: A Retrospective Cohort Study.

MLA

Nebrisi, Eslam El, et al. “Efficacy and Tolerability of Erenumab and Topiramate for Prevention of Chronic Migraine: A Retrospective Cohort Study.” Medicina (1010660X), vol. 60, no. 10, Oct. 2024, p. 1684. EBSCOhost, https://doi.org/10.3390/medicina60101684.

APA

Nebrisi, E. E., Ruwayya, Z. S. A., Alzayori, D. I., Alzayori, R. I., Chandran, S. B., & Elshafei, M. (2024). Efficacy and Tolerability of Erenumab and Topiramate for Prevention of Chronic Migraine: A Retrospective Cohort Study. Medicina (1010660X), 60(10), 1684. https://doi.org/10.3390/medicina60101684

Chicago

Nebrisi, Eslam El, Zainaba Suaad Ahmed Ruwayya, Dalya Ibrahim Alzayori, Ranya Ibrahim Alzayori, Shyam Babu Chandran, and Mohamed Elshafei. 2024. “Efficacy and Tolerability of Erenumab and Topiramate for Prevention of Chronic Migraine: A Retrospective Cohort Study.” Medicina (1010660X) 60 (10): 1684. doi:10.3390/medicina60101684.